Strix
26.1K

CVE-2022-48221

HIGHCVSS 7.5/10EPSS 0.51%

Last modified

CVE-2022-48221 is a high-severity vulnerability rated 7.5/10 on the CVSS scale. An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user writable directory. EPSS estimates a 0.51% chance of exploitation in the next 30 days.

Description

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user writable directory. Through a race condition and OpLock manipulation, these files can be overwritten by a standard user. They then get executed by the elevated installer. This gives a standard user full SYSTEM code execution (elevation of privileges).

Metrics

CVSS 3.1
7.5/10

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H

EPSS Probability
0.51%

39.3th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
GbgplcAcuant Acufill Sdk< 10.22.02.03

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2022-48221?
An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user writable directory. Through a race condition and OpLock manipulation, these files can be overwritten by a standard user. They then get executed by the elevated installer. This gives a standard user full SYSTEM code execution (elevation of privileges).
How severe is CVE-2022-48221?
CVE-2022-48221 has a CVSS score of 7.5/10 (HIGH severity). The EPSS model estimates a 0.51% probability of exploitation in the next 30 days.
How do I fix CVE-2022-48221?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2022-48221?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST